370 related articles for article (PubMed ID: 34248930)
1. Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.
Illouz T; Biragyn A; Iulita MF; Flores-Aguilar L; Dierssen M; De Toma I; Antonarakis SE; Yu E; Herault Y; Potier MC; Botté A; Roper R; Sredni B; London J; Mobley W; Strydom A; Okun E
Front Immunol; 2021; 12():621440. PubMed ID: 34248930
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system.
Bloemers BL; Broers CJ; Bont L; Weijerman ME; Gemke RJ; van Furth AM
Microbes Infect; 2010 Oct; 12(11):799-808. PubMed ID: 20685340
[TBL] [Abstract][Full Text] [Related]
3. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract.
Flerlage T; Boyd DF; Meliopoulos V; Thomas PG; Schultz-Cherry S
Nat Rev Microbiol; 2021 Jul; 19(7):425-441. PubMed ID: 33824495
[TBL] [Abstract][Full Text] [Related]
4. Pneumonia and respiratory infections in Down syndrome: A scoping review of the literature.
Santoro SL; Chicoine B; Jasien JM; Kim JL; Stephens M; Bulova P; Capone G
Am J Med Genet A; 2021 Jan; 185(1):286-299. PubMed ID: 33073471
[TBL] [Abstract][Full Text] [Related]
5. Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
Illouz T; Biragyn A; Frenkel-Morgenstern M; Weissberg O; Gorohovski A; Merzon E; Green I; Iulita F; Flores-Aguilar L; Dierssen M; De Toma I; Lifshitz H; Antonarakis SE; Yu E; Herault Y; Potier MC; Botté A; Roper R; Sredni B; Sarid R; London J; Mobley W; Strydom A; Okun E
Neuromolecular Med; 2021 Dec; 23(4):561-571. PubMed ID: 33660221
[TBL] [Abstract][Full Text] [Related]
6. Community respiratory virus infections in immunocompromised patients with cancer.
Whimbey E; Englund JA; Couch RB
Am J Med; 1997 Mar; 102(3A):10-8; discussion 25-6. PubMed ID: 10868137
[TBL] [Abstract][Full Text] [Related]
7. Down Syndrome and COVID-19: A Perfect Storm?
Espinosa JM
Cell Rep Med; 2020 May; 1(2):100019. PubMed ID: 32501455
[TBL] [Abstract][Full Text] [Related]
8. Respiratory viral infections and host responses; insights from genomics.
Troy NM; Bosco A
Respir Res; 2016 Nov; 17(1):156. PubMed ID: 27871304
[TBL] [Abstract][Full Text] [Related]
9. Community respiratory viruses in individuals with human immunodeficiency virus infection.
King JC
Am J Med; 1997 Mar; 102(3A):19-24; discussion 25-6. PubMed ID: 10868138
[TBL] [Abstract][Full Text] [Related]
10. A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022.
Mohebi L; Karami H; Mirsalehi N; Ardestani NH; Yavarian J; Mard-Soltani M; Mokhatri-Azad T; Salimi V
J Med Virol; 2022 Dec; 94(12):5802-5807. PubMed ID: 35961780
[TBL] [Abstract][Full Text] [Related]
11. Viral co-infection with human respiratory syncytial virus in suspected acute and severe respiratory tract infections during COVID-19 pandemic in Yaoundé, Cameroon, 2020-2021.
Moumbeket Yifomnjou MH; Monamele GC; Njankouo-Ripa M; Fatawou Modiyinji A; Ngoupo PA; Boyomo O; Njouom R
Influenza Other Respir Viruses; 2023 Mar; 17(3):e13131. PubMed ID: 36991539
[TBL] [Abstract][Full Text] [Related]
12. Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome.
Vita S; Di Bari V; Corpolongo A; Goletti D; Espinosa J; Petracca S; Palmieri F; Nicastri E;
Int J Infect Dis; 2021 Feb; 103():607-610. PubMed ID: 33271290
[TBL] [Abstract][Full Text] [Related]
13. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19.
De Toma I; Dierssen M
Sci Rep; 2021 Jan; 11(1):1930. PubMed ID: 33479353
[TBL] [Abstract][Full Text] [Related]
14. Difference between SARS-CoV-2, seasonal coronavirus, influenza, and respiratory syncytial virus infection in solid organ transplant recipients.
Mendoza MA; Motoa G; Raja MA; Frattaroli P; Fernandez A; Anjan S; Courel SC; Natori A; O'Brien CB; Phancao A; Sinha N; Vianna R; Loebe M; Ciancio G; Simkins J; Abbo L; Guerra G; Natori Y
Transpl Infect Dis; 2023 Feb; 25(1):e13998. PubMed ID: 36477946
[TBL] [Abstract][Full Text] [Related]
15. Redox Biology of Respiratory Viral Infections.
Khomich OA; Kochetkov SN; Bartosch B; Ivanov AV
Viruses; 2018 Jul; 10(8):. PubMed ID: 30049972
[TBL] [Abstract][Full Text] [Related]
16. SEROLOGICAL STUDY OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS IN INFANCY AND CHILDHOOD.
GARDNER PS; ELDERKIN FM; WALL AH
Br Med J; 1964 Dec; 2(5424):1570-3. PubMed ID: 14211759
[No Abstract] [Full Text] [Related]
17. Effects of Vertical Transmission of Respiratory Viruses to the Offspring.
Manti S; Leonardi S; Rezaee F; Harford TJ; Perez MK; Piedimonte G
Front Immunol; 2022; 13():853009. PubMed ID: 35359954
[TBL] [Abstract][Full Text] [Related]
18. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus.
Hedberg P; Johansson N; Ternhag A; Abdel-Halim L; Hedlund J; Nauclér P
BMC Infect Dis; 2022 Jan; 22(1):108. PubMed ID: 35100984
[TBL] [Abstract][Full Text] [Related]
19. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. IX. A comparison of infections with several respiratory pathogens in New York and New Orleans families.
Hall CE; Brandt CD; Frothingham TE; Spigland I; Cooney MK; Fox JP
Am J Epidemiol; 1971 Oct; 94(4):367-85. PubMed ID: 4329328
[No Abstract] [Full Text] [Related]
20. Uncertain effects of the pandemic on respiratory viruses.
Gomez GB; Mahé C; Chaves SS
Science; 2021 Jun; 372(6546):1043-1044. PubMed ID: 34083477
[No Abstract] [Full Text] [Related]
[Next] [New Search]
